Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Richard Klausner currently holds 130,000 shares of Lyell Immunopharma, Inc. (LYEL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Klausner has been a net seller of LYEL stock. They have purchased $0 and sold $11.1M worth of shares.
Richard Klausner's most recent insider trade was on Jun 14, 2024, when they sold 130,000 shares at $0.00 per share.
Richard Klausner serves as Executive at Lyell Immunopharma, Inc. (LYEL). They have executed 56 insider transactions totaling $11.1M over their tenure at the company.
Richard Klausner holds the position of Executive at Lyell Immunopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Richard Klausner has shown a selling trading pattern, with $0 in total purchases and $11.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Richard Klausner was on Mar 5, 2018, when they sold $61.4M worth of JUNO shares. This transaction involved 705,525 shares at $87.00 per share.
Richard Klausner currently owns 130,000 shares of Lyell Immunopharma, Inc. (LYEL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Richard Klausner's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Richard Klausner has 56 Form 4 filings on record as an insider at Lyell Immunopharma, Inc..
Set alerts for Richard Klausner and 40,000+ other insiders.